Lots of Patients with Refractory Sarcomas Considering Off-Label Checkpoint Inhibitor

Seth M. Pollack, MD, Fred Hutchinson Cancer Research Center, explains Lots of Patients with Refractory Sarcomas Considering Off-Label Checkpoint Inhibitor